img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
December 1, 2019
img
img
CEL-SCI Corporation
(NYSE: CVM)

$6,325,000

Follow-On Offering
Sole Bookrunner

December 1, 2019
img
Indonesia Energy Corp.
(NYSE: INDO)

$15,000,007


Sole Bookrunner

November 1, 2019
img
Arcimoto
(Nasdaq: FUV)

$9,000,000

Follow-On Offering
Joint Bookrunner

November 1, 2019
img
Document Security Systems
(NYSE: DSS)

$1,822,200

Private Placement
Placement Agent

October 1, 2019
img
Cocrystal Pharma
(Nasdaq: COCP)

$3,000,000

Follow-On Offering
Sole Bookrunner

October 1, 2019
img
Happiness Biotech
(Nasdaq: HAPP)

$11,000,000


Co-Manager

October 1, 2019
img
Indonesia Energy Corp.
(NYSE: INDO)


Financial Advisor

August 1, 2019
img
img
Stemline Therapeutics, Inc.
(Nasdaq: STML)

$76,250,000

Follow-On Offering
Co-Manager

July 1, 2019
img
img
Tonix Pharmaceuticals
(Nasdaq: TNXP)

$5,400,000

Follow-On Offering
Sole Bookrunner

July 1, 2019
img
img
Sigma Labs
(Nasdaq: SGLB)

$2,300,000

Follow-On Offering
Sole Bookrunner

June 1, 2019
img
img
Gladstone Land
(Nasdaq: LAND)

$23,460,000

Follow-On Offering
Co-Manager

June 1, 2019
img
Document Security Systems
(NYSE: DSS)

$5,859,593

Follow-On Offering
Sole Bookrunner

1 … 31 32 33 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Read More icon Read More icon
  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.